Unfavourable outcome of glucocorticoid treatment in suspected idiopathic pulmonary fibrosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1843|23|3|311-317

ISSN： 1323-7799

Source： RESPIROLOGY (ELECTRONIC), Vol.23, Iss.3, 2018-03, pp. : 311-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment

By  

Respiration, Vol. 93, Iss. 5, 2017-03 ,pp. : 363-378

Karger

Access to resources Recommend Favorite

Treatment doses in idiopathic pulmonary fibrosis: The devil is in the detail

By  

RESPIROLOGY (ELECTRONIC), Vol. 23, Iss. 3, 2018-03 ,pp. : 244-245

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Outcome and Prognostic Factors

By  

Respiration, Vol. 83, Iss. 1, 2011-08 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

Acute Exacerbations of Idiopathic Pulmonary Fibrosis

By  

Respiration, Vol. 86, Iss. 4, 2013-10 ,pp. : 265-274

Karger

Access to resources Recommend Favorite

Elevated CC Chemokine Level in Bronchoalveolar Lavage Fluid Is Predictive of a Poor Outcome of Idiopathic Pulmonary Fibrosis

By  

Respiration, Vol. 78, Iss. 3, 2009-03 ,pp. : 285-292

Karger

Access to resources Recommend Favorite